The UK Markey Cancer Center’s Molecular Tumor Board, the first of its kind in the Commonwealth, uses precision medicine to analyze the genetic makeup of a patient’s cancer and then enlists a team of experts to determine the best treatment for that unique cancer – and that patient. It’s just one way we’re harnessing the power of advanced medicine to tackle the very real challenges cancer poses for our patients and our state.
For more information visit [ Ссылка ].
